EC Number |
Inhibitors |
Structure |
---|
1.14.15.3 | (E)-N'-(4-butyl-2-methylphenyl)-N-hydroxyformimidamide |
HET0016, almost completely abolishes hypotonic solutions- or 2,4,6-trinitrophenol-induced enhancement of receptor-activated cationic current I(TRPC6) |
|
1.14.15.3 | (E)-N'-(4-butyl-2-methylphenyl)-N-hydroxyformimidamide |
HET0016, diminishes TRPC6-like channel activity in myocytes |
|
1.14.15.3 | 1,1-dichloroethene |
50% of BMO activity is irreversibly lost after oxidation of approximately 25 nmol/mg protein |
|
1.14.15.3 | 1,2-cis-dichloroethene |
50% of BMO activity is lost after oxidation of 120 nmol/mg protein |
|
1.14.15.3 | 1,2-trans-dichloroethene |
50% of BMO activity is lost after oxidation of 20 nmol/mg protein |
|
1.14.15.3 | 1,7-octadiyne |
inhibits oxidation of methyl tert-butyl ether; putative mechanism-based inactivator, strongly inhibitory at 0.1% (v/v) |
|
1.14.15.3 | 1-octyne |
acts as a mechanism-based inhibitor of AlkB |
|
1.14.15.3 | 1-octyne |
irreversible inhibition, oxidation product hexylketene or its equivalent, covalently binds to AlkB |
|
1.14.15.3 | 11-dodecynoic acid |
completely inhibited lauric acid omega-hydroxylation |
|
1.14.15.3 | 17-octadecynoic acid |
almost completely abolishes hypotonic solutions- or 2,4,6-trinitrophenol-induced enhancement of receptor-activated cationic current I(TRPC6) |
|